Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alkaline phosphatase in severely burned ICU patients
2019-004826-12Phase 2Completed
- Sponsor
- Association of Dutch Burn Centres
- Start
- Jul 2021
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bovine intestinal alkaline phosphatase in burn injury, sponsored by Association of Dutch Burn Centres. Primary endpoint: Safety. Started Jul 2021; status: completed.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
burn injury
Beyond the preview
Go deeper on 2019-004826-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004826-12.